Skip to content

Clinical trials

Phase 1/2 Liver Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Phase 1/2 Country / region: China Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20091
20121
20131
20142
20158
20162
20171
20191
20201
20211
20223
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting7
Unknown status6
Active, not recruiting2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fuda Cancer Hospital, Guangzhou8
Essen Biotech2
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC1
Arbutus Biopharma Corporation1
Beijing Biotech1
Bristol-Myers Squibb1
Chinese PLA General Hospital1
Chongqing Precision Biotech Co., Ltd1
Cure&Sure Biotech Co., LTD1
DualityBio Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms30
Carcinoma, Hepatocellular7
Breast Neoplasms6
Colorectal Neoplasms6
Lung Neoplasms5
Neoplasm Metastasis4
Neoplasms4
Ovarian Neoplasms4
Pancreatic Neoplasms4
Stomach Neoplasms4

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.